Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
111,247
datasets available to search
ShareScore release 0.9.0
Dataset results
111,247 results for “cells”
Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)
ClinicalTrials.gov study NCT03279081. IPD Sharing: YES. Countries: 15. Publications: 0.
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)
ClinicalTrials.gov study NCT01578499. IPD Sharing: YES. Countries: 12. Publications: 5.
Age of Blood in Sickle Cell Transfusion
ClinicalTrials.gov study NCT03704922. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03957590. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
ClinicalTrials.gov study NCT04150913. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT01492088. IPD Sharing: YES. Countries: 8. Publications: 3.
Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
ClinicalTrials.gov study NCT04703192. IPD Sharing: YES. Countries: 12. Publications: 1.
Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib
ClinicalTrials.gov study NCT05068440. IPD Sharing: YES. Countries: 1. Publications: 0.
Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss
ClinicalTrials.gov study NCT05134480. IPD Sharing: YES. Countries: 1. Publications: 3.
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
ClinicalTrials.gov study NCT01235962. IPD Sharing: YES. Countries: 26. Publications: 2.
Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoi
ClinicalTrials.gov study NCT03945773. IPD Sharing: YES. Countries: 7. Publications: 1.
DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03599518. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03783442. IPD Sharing: YES. Countries: 16. Publications: 2.
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
ClinicalTrials.gov study NCT03596866. IPD Sharing: YES. Countries: 20. Publications: 2.
Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
ClinicalTrials.gov study NCT01895361. IPD Sharing: YES. Countries: 3. Publications: 3.
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
ClinicalTrials.gov study NCT04478123. IPD Sharing: YES. Countries: 1. Publications: 1.
LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01685138. IPD Sharing: YES. Countries: 18. Publications: 2.
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03505710. IPD Sharing: YES. Countries: 5. Publications: 3.
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
ClinicalTrials.gov study NCT00782067. IPD Sharing: UNDECIDED. Countries: 12. Publications: 3.
Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04154943. IPD Sharing: YES. Countries: 3. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.